Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Match Group
MTCH
|
+$1.51B |
| 2 |
Peloton Interactive
PTON
|
+$792M |
| 3 |
Twilio
TWLO
|
+$558M |
| 4 |
Teladoc Health
TDOC
|
+$484M |
| 5 |
Visa
V
|
+$365M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.24B |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
+$702M |
| 3 |
Microsoft
MSFT
|
+$688M |
| 4 |
Mastercard
MA
|
+$665M |
| 5 |
Boeing
BA
|
+$548M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.06% |
| 2 | Consumer Discretionary | 23.86% |
| 3 | Communication Services | 13.34% |
| 4 | Healthcare | 10.36% |
| 5 | Financials | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Zoom
ZM
$29.5B
| $1.42M | ﹤0.01% |
3,014
-2,245
| -43% | -$718K |
|
527
Brookdale Senior Living
BKD
$3.45B
| $1.4M | ﹤0.01% |
549,424
+303,301
| +123% | +$836K |
|
|
SCS
528
DELISTED
Steelcase
SCS
| $1.39M | ﹤0.01% |
137,007
+6,696
| +5% | +$72K |
|
|
CVSA
529
Covista Inc
CVSA
$4.42B
| $1.38M | ﹤0.01% |
56,208
+31,758
| +130% | +$1.03M |
|
|
IMTXW
530
DELISTED
Immatics N.V. Warrants
IMTXW
| $1.35M | ﹤0.01% |
+386,035
| New | +$1.29M |
|
531
Buckle
BKE
$2.34B
| $1.31M | ﹤0.01% |
64,343
+15,464
| +32% | +$280K |
|
|
AEL
532
DELISTED
American Equity Investment Life Holding Company
AEL
| $1.3M | ﹤0.01% |
59,148
+37,513
| +173% | +$896K |
|
533
Avery Dennison
AVY
$13.3B
| $1.28M | ﹤0.01% |
9,984
-2,422
| -20% | -$286K |
|
|
B
534
DELISTED
Barnes Group Inc.
B
| $1.27M | ﹤0.01% |
+35,569
| New | +$1.35M |
|
|
KA
535
DELISTED
Kineta, Inc. Common Stock
KA
| $1.26M | ﹤0.01% |
+8,184
| New | +$1.54M |
|
536
AMN Healthcare
AMN
$1.27B
| $1.24M | ﹤0.01% |
21,189
+6,322
| +43% | +$333K |
|
|
VIVO
537
DELISTED
Meridian Bioscience Inc
VIVO
| $1.24M | ﹤0.01% |
72,734
+49,508
| +213% | +$962K |
|
538
Crocs
CROX
$6.58B
| $1.2M | ﹤0.01% |
28,121
+9,624
| +52% | +$372K |
|
539
The Greenbrier Companies
GBX
$1.54B
| $1.18M | ﹤0.01% |
+40,048
| New | +$1.08M |
|
540
Axcelis
ACLS
$4.2B
| $1.17M | ﹤0.01% |
+53,056
| New | +$1.35M |
|
|
DOOR
541
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $1.17M | ﹤0.01% |
11,859
+1,029
| +10% | +$91.3K |
|
|
ATSG
542
DELISTED
Air Transport Services Group
ATSG
| $1.16M | ﹤0.01% |
46,389
+21,105
| +83% | +$527K |
|
543
PUT
Inovio Pharmaceuticals
INO
$70M
| $1.16M | ﹤0.01% |
+8,333
| New | +$1.74M |
|
|
DHR.PRA
544
DELISTED
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
| $1.13M | ﹤0.01% |
764
-508
| -40% | -$713K |
|
|
BSX.PRA
545
DELISTED
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
| $1.13M | ﹤0.01% |
10,065
-935
| -9% | -$105K |
|
546
Cannae Holdings
CNNE
$654M
| $1.11M | ﹤0.01% |
+29,714
| New | +$1.13M |
|
547
Toll Brothers
TOL
$14.5B
| $1.09M | ﹤0.01% |
22,384
-14,859
| -40% | -$601K |
|
548
MarineMax
HZO
$796M
| $1M | ﹤0.01% |
+39,001
| New | +$1.07M |
|
549
Arcturus Therapeutics
ARCT
$178M
| $992K | ﹤0.01% |
23,116
-138,308
| -86% | -$6.87M |
|
550
Medpace
MEDP
$16.4B
| $990K | ﹤0.01% |
8,859
-1,154
| -12% | -$133K |
|
Similar funds
Jennison Associates's Q3 2020 Portfolio in Review
As of Q3 2020, Jennison Associates held 720 positions worth $124B, up 12% from $111B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Jennison Associates's Q3 2020 filing shows 100 new, 258 increased, 257 reduced and 100 closed positions. Its largest new stake was Peloton Interactive: 10,766,951 shares worth $1.07B. The largest sale was Alibaba, an estimated $1.24B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q3 2020 buy was Peloton Interactive: 10,766,951 shares worth $1.07B.
- Jennison Associates added most to Match Group in Q3 2020, an estimated $1.51B increase.
- Jennison Associates's biggest Q3 2020 reduction was Alibaba, cutting an estimated $1.24B.
- Jennison Associates fully exited Boeing in Q3 2020, selling an estimated $548M.
- Jennison Associates's ten largest holdings make up 42% of its $124B portfolio in Q3 2020.
- Jennison Associates opened 100 new positions and closed 100 in Q3 2020.
- Jennison Associates's portfolio value rose 12% quarter-over-quarter to $124B.
Based on Jennison Associates's 13F filing for Q3 2020, filed 4 Nov 2020.